COPD Care Pathway Among Patients With Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-27

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metabolic and Microbial Profiling of Lung Cancer

NCT03998189

Nonsmall Cell Lung Cancer Nonsmall Cell Lung Cancer Stage

TERMINATED NA

Prevalence of COPD in Our Lung Cancer Population, Compared to Controls

NCT02603627

COPD Lung Cancer Smoking

UNKNOWN

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

NCT06016569

Lung Cancer

RECRUITING NA

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

NCT05049837

Lung Cancer Cancer of Thorax

RECRUITING

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

NCT02190864

Particularly Rural/Urban Residence Gender Age +2 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective: To design a feasible COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.

Secondary Objectives:

* To identify, characterize, and explain the treatment burdens of COPD and cancer as comorbidities, as reported by patients and providers.
* To identify, characterize, and explain barriers to COPD care in the oncology clinic, as reported by patients and providers.
* To identify, characterize, and explain important and feasible components of COPD care for patients with cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease Lung Cancer Head and Neck Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational Phase 1

Participants complete surveys

Observational Phase 1

Intervention Type OTHER

Noninterventional study

Observational Phase 2, Group I

Participants complete an interview and participate in a focus group on study.

Observational Phase 2, Group I

Intervention Type OTHER

Noninterventional study

Observational Phase 2, Group II

Participants complete an interview and participate in guided tours of the oncology clinic on study.

Observational Phase 2, Group II

Intervention Type OTHER

Noninterventional study

Observational Phase 3

A subset of interested participants from Phase 2 participate in a workshop on study to develop a final draft of the COPD care pathway.

Observational Phase 3

Intervention Type OTHER

Noninterventional study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational Phase 1

Noninterventional study

Intervention Type OTHER

Observational Phase 2, Group I

Noninterventional study

Intervention Type OTHER

Observational Phase 2, Group II

Noninterventional study

Intervention Type OTHER

Observational Phase 3

Noninterventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:

1. patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
2. provider who currently works at least part-time in a medical oncology clinic or
3. provider who works at least part-time to care for patients with known or suspected COPD.

A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
* Ability to understand and agree to participate on the study as described by the study information sheet.
* Capability of speaking or reading English.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes